Prime Medicine to Present at Jefferies Global Healthcare Conference
Prime Medicine (Nasdaq: PRME) announced that Allan Reine, M.D., Chief Executive Officer, will speak in a fireside chat at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025 at 12:00 noon GMT (7:00 a.m. ET) in London.
A live audio webcast will be available under “Events & Presentations” in the News & Events section of the company website at www.primemedicine.com, and a replay will be accessible on the website for 90 days after the event.
Prime Medicine (Nasdaq: PRME) ha annunciato che Allan Reine, M.D., Chief Executive Officer, interverrà in una fireside chat alla Jefferies Global Healthcare Conference martedì 18 novembre 2025 alle 12:00 GMT (7:00 ET) a Londra.
Una trasmissione audio in diretta sarà disponibile nella sezione Eventi e Presentazioni delle News & Events sul sito della società all'indirizzo www.primemedicine.com, e una replica sarà accessibile sul sito per 90 giorni dopo l'evento.
Prime Medicine (Nasdaq: PRME) anunció que Allan Reine, M.D., Director Ejecutivo, participará en una charla informal en la Jefferies Global Healthcare Conference el martes 18 de noviembre de 2025 a las 12:00 GMT (7:00 a.m. ET) en Londres.
Una transmisión de audio en vivo estará disponible bajo “Noticias y Eventos” en la sección de Eventos y Presentaciones del sitio web de la empresa en www.primemedicine.com, y una réplica estará accesible en el sitio web durante 90 días después del evento.
Prime Medicine (나스닥: PRME)가 Allan Reine 박사, 최고경영자(CEO)가 Jefferies Global Healthcare Conference에서 화로 대화(fireside chat)를 가지며 2025년 11월 18일 화요일 12:00 GMT(동부표준시 7:00)에 런던에서 발표한다고 발표했습니다.
라이브 오디오 웹캐스트는 회사 웹사이트의 뉴스 및 이벤트 섹션의 이벤트 및 프레젠테이션 아래에서 www.primemedicine.com으로 제공되며, 이벤트 후 90일간 웹사이트에서 재생도 이용 가능합니다.
Prime Medicine (Nasdaq: PRME) a annoncé que Allan Reine, M.D., Directeur général, prendra part à une conversation au coin du feu lors de la Jefferies Global Healthcare Conference le mardi 18 novembre 2025 à 12h00 GMT (7h00 ET) à Londres.
Une diffusion audio en direct sera disponible dans la section Événements et Présentations des News & Events du site de l’entreprise à l’adresse www.primemedicine.com, et une rediffusion sera accessible sur le site pour 90 jours après l’événement.
Prime Medicine (Nasdaq: PRME) gab bekannt, dass Allan Reine, M.D., Chief Executive Officer, in einem Fireside-Chat bei der Jefferies Global Healthcare Conference am Dienstag, dem 18. November 2025 um 12:00 Uhr GMT (7:00 Uhr ET) in London sprechen wird.
Eine Live-Audio-Übertragung wird unter Events & Presentations im Bereich News & Events der Unternehmenswebsite unter www.primemedicine.com verfügbar sein, und eine Wiederholung wird auf der Website für 90 Tage nach der Veranstaltung abrufbar sein.
Prime Medicine (Nasdaq: PRME) أعلنت أن الدكتور آلان راين، الرئيس التنفيذي، سيشارك في دردشة fireside في مؤتمر Jefferies العالمي للرعاية الصحية يوم الثلاثاء 18 نوفمبر 2025 الساعة 12:00 ظهراً بتوقيت GMT (7:00 صباحاً بتوقيت شرق الولايات المتحدة) في لندن.
سيكون هناك بث صوتي حي متاح تحت قسم “الأحداث والعروض” في قسم الأخبار والفعاليات على موقع الشركة على العنوان www.primemedicine.com، وسيكون بالإمكان الوصول إلى إعادة البث على الموقع لمدة 90 يومًا بعد الحدث.
- None.
- None.
CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Allan Reine, M.D., Chief Executive Officer of Prime Medicine, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 12:00 noon GMT (7:00 a.m. ET) in London, United Kingdom.
A live audio webcast of the fireside chat will be available under “Events & Presentations” in the News & Events section of the Company’s website at www.primemedicine.com. A replay of the webcast will be available on the Prime Medicine website for 90 days following the event.
About Prime Medicine
Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types. Taken together, Prime Editing’s versatile gene editing capabilities could unlock opportunities across thousands of potential indications.
Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: liver, lung, and immunology and oncology. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path, and each expected to provide the foundation for expansion into additional opportunities. Over time, the Company intends to maximize Prime Editing’s broad and versatile therapeutic potential, as well as the modularity of the Prime Editing platform, to rapidly and efficiently expand beyond the diseases in its current pipeline, potentially including additional genetic diseases, immunological diseases, cancers, infectious diseases, and targeting genetic risk factors in common diseases, which collectively impact millions of people. For more information, please visit www.primemedicine.com.
© 2025 Prime Medicine, Inc. All rights reserved. PRIME MEDICINE, the Prime Medicine logos, and PASSIGE are trademarks of Prime Medicine, Inc. All other trademarks referred to herein are the property of their respective owners.
Investor and Media Contacts
Gregory Dearborn
Prime Medicine
857-209-0696
gdearborn@primemedicine.com
Hannah Deresiewicz
Precision AQ
212-362-1200
hannah.deresiewicz@precisionaq.com
FAQ
When will Prime Medicine (PRME) present at the Jefferies Global Healthcare Conference?
Who from Prime Medicine will speak at the Jefferies Global Healthcare Conference on November 18, 2025?
How can investors listen to Prime Medicine (PRME) at the Jefferies Global Healthcare Conference?
Will the Prime Medicine (PRME) webcast from November 18, 2025 be available after the event?
Where is the Jefferies Global Healthcare Conference presentation by Prime Medicine taking place?
